RU99122603A - NEW PYRIMIDINE DERIVATIVES AND METHODS FOR THEIR PRODUCTION - Google Patents
NEW PYRIMIDINE DERIVATIVES AND METHODS FOR THEIR PRODUCTIONInfo
- Publication number
- RU99122603A RU99122603A RU99122603/04A RU99122603A RU99122603A RU 99122603 A RU99122603 A RU 99122603A RU 99122603/04 A RU99122603/04 A RU 99122603/04A RU 99122603 A RU99122603 A RU 99122603A RU 99122603 A RU99122603 A RU 99122603A
- Authority
- RU
- Russia
- Prior art keywords
- hydrogen
- methyl
- formula
- following formula
- compound
- Prior art date
Links
- 150000003230 pyrimidines Chemical class 0.000 title claims 10
- 229940083082 Pyrimidine derivatives acting on arteriolar smooth muscle Drugs 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 25
- 239000001257 hydrogen Substances 0.000 claims 25
- -1 1-naphthylmethyl Chemical group 0.000 claims 24
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 23
- 150000001875 compounds Chemical class 0.000 claims 16
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 15
- 229910052736 halogen Inorganic materials 0.000 claims 7
- 150000002367 halogens Chemical class 0.000 claims 7
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 4
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims 3
- 125000004849 alkoxymethyl group Chemical group 0.000 claims 3
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims 3
- 230000003993 interaction Effects 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 2
- 125000005078 alkoxycarbonylalkyl group Chemical group 0.000 claims 2
- 125000004848 alkoxyethyl group Chemical group 0.000 claims 2
- 125000006515 benzyloxy alkyl group Chemical group 0.000 claims 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Substances O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims 2
- 150000002431 hydrogen Chemical class 0.000 claims 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 2
- 125000004372 methylthioethyl group Chemical group [H]C([H])([H])SC([H])([H])C([H])([H])* 0.000 claims 2
- 125000001064 morpholinomethyl group Chemical group [H]C([H])(*)N1C([H])([H])C([H])([H])OC([H])([H])C1([H])[H] 0.000 claims 2
- 125000001624 naphthyl group Chemical group 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 1
- XJUZRXYOEPSWMB-UHFFFAOYSA-N Chloromethyl methyl ether Chemical compound COCCl XJUZRXYOEPSWMB-UHFFFAOYSA-N 0.000 claims 1
- 208000008469 Peptic Ulcer Diseases 0.000 claims 1
- 238000005660 chlorination reaction Methods 0.000 claims 1
- 229940061627 chloromethyl methyl ether Drugs 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
Claims (13)
где когда А представляет -NH-B, где В представляет (С3-С7)-циклоалкил, (C1-С3)-алкоксиэтил, 1-нафтилметил, 4-метилтиазол-2-ил или 4-фенилтиазол-2-ил;
R1 представляет водород или метил и
R2, R3, R4 и R5 представляют водород или когда А представляет группу формулы (II)
когда R1 представляет гидроксиметил или (C1-С3)-алкоксиметил;
R2, R3, R4, R5 и R6 представляют водород и
R7 представляет водород или галоген или когда R1 представляет водород или метил;
R7 представляет водород или галоген и один или два из R2, R3, R4, R5 и R6 представляют гидрокси, метокси или группу формулы (III)
где Z представляет (C1-C4)-алкил, замещенный или незамещенный (C1-C4)-алкенил, циклоалкил, бензилоксиалкил, алкоксикарбонилалкил, морфолинометил, пиперидинометил, 4-замещенный пиперазинометил, замещенный или незамещенный фенил, нафтил, замещенный или незамещенный бензил, тиофен-2-ил-метил, 1-замещенный пирролидин-2-ил или -СНR8NНR9, где R8 представляет водород, метил, изопропил, бензил, бензилоксиметил, метилтиоэтил, бензилоксикарбонилметил, карбамоилметил, карбамоилэтил или 1-бензилимидазол-4-илметил, и R9 представляет водород или трет-бутоксикарбонил; а другие представляют водород или метил, или
его фармацевтически приемлемые соли.1. A pyrimidine derivative of the formula (I)
wherein when A represents —NH-B, wherein B represents (C 3 -C 7 ) cycloalkyl, (C 1 -C 3 ) alkoxyethyl, 1-naphthylmethyl, 4-methylthiazol-2-yl or 4-phenylthiazol-2- silt;
R 1 represents hydrogen or methyl and
R 2 , R 3 , R 4 and R 5 are hydrogen or when A represents a group of formula (II)
when R 1 is hydroxymethyl or (C 1 -C 3 ) alkoxymethyl;
R 2 , R 3 , R 4 , R 5 and R 6 are hydrogen and
R 7 is hydrogen or halogen, or when R 1 is hydrogen or methyl;
R 7 is hydrogen or halogen and one or two of R 2 , R 3 , R 4 , R 5 and R 6 are hydroxy, methoxy or a group of formula (III)
where Z is (C 1 -C 4 ) -alkyl, substituted or unsubstituted (C 1 -C 4 ) -alkenyl, cycloalkyl, benzyloxyalkyl, alkoxycarbonylalkyl, morpholinomethyl, piperidinomethyl, 4-substituted piperazinomethyl, substituted or unsubstituted phenyl, naphthyl, substituted or unsubstituted benzyl, thiophen-2-yl-methyl, 1-substituted pyrrolidin-2-yl or -CHR 8 NHR 9 , where R 8 is hydrogen, methyl, isopropyl, benzyl, benzyloxymethyl, methylthioethyl, benzyloxycarbonylmethyl, carbamoylmethyl, carbamoyl ethyl, or 1 benzylimidazol-4-ylmethyl, and R 9 is hydrogen or tert-butoxy carbonyl; and the others are hydrogen or methyl, or
its pharmaceutically acceptable salts.
где R1 представляет водород или метил; и А' представляет -NH-B, где В представляет (С3-С7)-циклоалкил, (C1-С3)-алкоксиэтил, 1-нафтилметил, 4-метилтиазол-2-ил или 4-фенилтиазол-2-ил.2. The compound according to claim 1, having the formula (I-1)
where R 1 represents hydrogen or methyl; and A 'is -NH-B, where B is (C 3 -C 7 ) cycloalkyl, (C 1 -C 3 ) alkoxyethyl, 1-naphthylmethyl, 4-methylthiazol-2-yl or 4-phenylthiazol-2- silt
где R1 представляет водород или метил; R7 представляет водород или галоген; один или два из R'2, R'3, R'4, R'5 и R'6 представляют гидрокси или метокси, а остальные представляют водород или метил.3. The compound according to claim 1, having the formula (I-2)
where R 1 represents hydrogen or methyl; R 7 is hydrogen or halogen; one or two of R ′ 2 , R ′ 3 , R ′ 4 , R ′ 5 and R ′ 6 are hydroxy or methoxy, and the others are hydrogen or methyl.
где R1 представляет водород или метил; R7 представляет водород или галоген; один или два из R''2, R''3, R''4, R''5 и R''6 представляют группу формулы (III)
где Z представляет (C1-C4)-алкил, замещенный или незамещенный (C1-C4)-алкенил, (С3-С6)-циклоалкил, бензилоксиалкил, алкоксикарбонилалкил, морфолинометил, пиперидинометил, 4-замещенный пиперазинометил, замещенный или незамещенный фенил, нафтил, замещенный или незамещенный бензил, тиофен-2-ил-метил, 1-замещенный пирролидин-2-ил или -CHR8NHR9, где R8 представляет водород, метил, изопропил, бензил, бензилоксиметил, метилтиоэтил, бензилоксикарбонилметил, карбамоилметил, карбамоилэтил или 1-бензилимидазол-4-илметил и R9 представляет водород или трет-бутоксикарбонил и остальные представляют водород или метил.4. The compound according to claim 1, having the formula (I-3)
where R 1 represents hydrogen or methyl; R 7 is hydrogen or halogen; one or two of R " 2 , R" 3 , R " 4 , R" 5 and R " 6 represent a group of formula (III)
where Z is (C 1 -C 4 ) -alkyl, substituted or unsubstituted (C 1 -C 4 ) -alkenyl, (C 3 -C 6 ) -cycloalkyl, benzyloxyalkyl, alkoxycarbonylalkyl, morpholinomethyl, piperidinomethyl, 4-substituted piperazinomethyl, substituted or unsubstituted phenyl, naphthyl, substituted or unsubstituted benzyl, thiophen-2-yl-methyl, 1-substituted pyrrolidin-2-yl or -CHR 8 NHR 9 , where R 8 is hydrogen, methyl, isopropyl, benzyl, benzyloxymethyl, methylthioethyl, benzyloxycarbonylmethyl, carbamoylmethyl, carbamoylethyl or 1-benzylimidazol-4-ylmethyl and R 9 is hydrogen or tert-bu toxycarbonyl and the others are hydrogen or methyl.
где R1 представляет гидроксиметил или (C1-С3)-алкоксиметил и R7 представляет водород или галоген.5. The compound according to claim 1, having the formula (I-4)
where R 1 is hydroxymethyl or (C 1 -C 3 ) alkoxymethyl and R 7 is hydrogen or halogen.
где R1 представляет водород или метил и А" представляет -NH-B, где В представляет (С3-С7)-циклоалкил, (C1-С3)-алкоксиэтил или 1-нафтилметил.6. The method of obtaining the pyrimidine derivative of the following formula (I-1a), characterized in that it involves the interaction of the compound of the formula (IV) below with A "H
where R 1 represents hydrogen or methyl and A "represents -NH-B, where B represents (C 3 -C 7 ) -cycloalkyl, (C 1 -C 3 ) -alkoxyethyl or 1-naphthylmethyl.
где R1 представляет водород или метил и R10 представляет метил или фенил.7. The method of obtaining the pyrimidine derivative of the following formula (I-1b), characterized in that it includes the chlorination of the compound of the following formula (V) to form the compound of the following formula (VI) and the interaction of the compound of the formula (VI) C1-R 1 -1.2 , 3,4-tetrahydroisoquinoline
where R 1 represents hydrogen or methyl and R 10 represents methyl or phenyl.
где R1, R'2, R'3, R'5, R'6 и R7 имеют значения, указанные в случае формулы (I-2) и R'''4 представляет водород или метил.8. The method of obtaining the pyrimidine derivative of the following formula (I-2a), characterized in that it comprises reacting a compound of the following formula (VII) with a compound of the following formula (VIII)
where R 1 , R ' 2 , R' 3 , R ' 5 , R' 6 and R 7 have the meanings indicated in the case of formula (I-2) and R "' 4 represents hydrogen or methyl.
где R1 и R7 имеют значения, указанные в случае формулы (I-2); R'''2, R'''3, R'''5 и R'''6 представляют водород или метил, или один из R'''2, R'''3, R'''5 и R'''6 представляет гидрокси или метокси.9. The method of obtaining the pyrimidine derivative of the following formula (I-2ba), characterized in that it includes the interaction of the compound of the following formula (XII) with p-formaldehyde in formalin
where R 1 and R 7 have the meanings specified in the case of formula (I-2); R "" 2 , R "" 3 , R "" 5 and R "" 6 represent hydrogen or methyl, or one of R "" 2 , R "" 3 , R "" 5 and R "6" represents hydroxy or methoxy.
где R1, R'''2, R'''3, R'''5, R'''6 и R7 имеют значения, указанные в случае формулы (I-2ba).10. The method of obtaining the pyrimidine derivative of the following formula (I-2bb), characterized in that it comprises reacting the compound of the following formula (XII) with chloromethyl methyl ether
where R 1 , R "' 2 , R"' 3 , R "' 5 , R"' 6 and R 7 have the meanings indicated in the case of formula (I-2ba).
где R1, R''2, R''3, R''4, R''5, R''6, R7 и Z имеют значения, указанные в случае формулы (I-3), один или два из R''''2, R''''3, R''''4, R''''5 и R''''6 представляют гидрокси, а остальные представляют водород; и Х представляет галоген или гидрокси.11. The method of obtaining the pyrimidine derivative of the following formula (I-3), characterized in that it comprises reacting a compound of the following formula (XIII) with a compound of the following formula (XIV)
where R 1 , R " 2 , R" 3 , R " 4 , R" 5 , R " 6 , R 7 and Z have the meanings indicated in the case of formula (I-3), one or two of R "" 2 , R "" 3 , R "" 4 , R "" 5 and R "" 6 represent hydroxy, and the others are hydrogen; and X is halogen or hydroxy.
где R1 представляет гидроксиметил или (C1-С3)-алкоксиметил; и R7 представляет водород или галоген.12. The method of obtaining the pyrimidine derivative of the following formula (I-4), characterized in that it comprises reacting a compound of the following formula (XV) with a compound of the following formula (XVI)
where R 1 represents hydroxymethyl or (C 1 -C 3 ) alkoxymethyl; and R 7 is hydrogen or halogen.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1997/10863 | 1997-03-27 | ||
KR19970010862 | 1997-03-27 | ||
KR97/10863 | 1997-03-27 | ||
KR97/10862 | 1997-03-27 | ||
KR19970010863 | 1997-03-27 | ||
KR1997/10862 | 1997-03-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU99122603A true RU99122603A (en) | 2001-07-27 |
RU2203894C2 RU2203894C2 (en) | 2003-05-10 |
Family
ID=26632616
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU99122603/04A RU2203894C2 (en) | 1997-03-27 | 1998-03-24 | Novel derivatives of pyrimidine (variants) |
Country Status (22)
Country | Link |
---|---|
US (1) | US6352993B1 (en) |
EP (1) | EP1015444B1 (en) |
JP (1) | JP3176379B2 (en) |
KR (1) | KR100278857B1 (en) |
CN (1) | CN1118464C (en) |
AR (1) | AR012181A1 (en) |
AT (1) | ATE241613T1 (en) |
AU (1) | AU720385B2 (en) |
BR (1) | BR9808070A (en) |
CA (1) | CA2284795C (en) |
DE (1) | DE69815126T2 (en) |
DK (1) | DK1015444T3 (en) |
ES (1) | ES2200324T3 (en) |
HK (1) | HK1026418A1 (en) |
HU (1) | HUP0000851A3 (en) |
IN (1) | IN188411B (en) |
PT (1) | PT1015444E (en) |
RU (1) | RU2203894C2 (en) |
TR (1) | TR199902383T2 (en) |
TW (1) | TW542831B (en) |
UY (1) | UY24938A1 (en) |
WO (1) | WO1998043968A1 (en) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100272471B1 (en) | 1998-11-17 | 2000-11-15 | 김선진 | Novel pyrimidine derivatives and processes for the preparation thereof |
US6852739B1 (en) | 1999-02-26 | 2005-02-08 | Nitromed Inc. | Methods using proton pump inhibitors and nitric oxide donors |
AR038368A1 (en) | 2002-02-01 | 2005-01-12 | Novartis Ag | N-PYRIMIDIN-2-IL-AMINAS SUBSTITUTED COMPOUNDS AS IGE INHIBITORS, A PHARMACEUTICAL COMPOSITION AND THE USE OF SUCH COMPOUNDS FOR THE PREPARATION OF A MEDICINAL PRODUCT |
CA2493618A1 (en) | 2002-08-01 | 2004-02-12 | Nitromed, Inc. | Nitrosated proton pump inhibitors, compositions and methods of use |
CA2533397A1 (en) * | 2003-07-22 | 2005-02-03 | Neurogen Corporation | Substituted pyridin-2-ylamine analogues |
JP4800216B2 (en) * | 2003-10-24 | 2011-10-26 | エグゼリクシス, インコーポレイテッド | p70S6 kinase modulator and methods of use |
AU2004285394B2 (en) | 2003-11-03 | 2009-01-08 | Astrazeneca Ab | Imidazo (1,2-A) pyridine derivatives for the treatment of silent gastro-esophageal reflux |
KR101122376B1 (en) * | 2005-03-09 | 2012-03-26 | 주식회사유한양행 | Novel 5,6-dimethylpyrimidine derivatives and processes for the preparation thereof |
EP1940804A2 (en) * | 2005-10-14 | 2008-07-09 | NeuroSearch A/S | Novel pyrimidine-2,4-diamine derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
US8367684B2 (en) * | 2007-06-13 | 2013-02-05 | Valeant Pharmaceuticals International | Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators |
PT2308877E (en) | 2008-08-05 | 2014-05-02 | Daiichi Sankyo Co Ltd | Imidazopyridin-2-one derivatives |
GB0908394D0 (en) | 2009-05-15 | 2009-06-24 | Univ Leuven Kath | Novel viral replication inhibitors |
GB0913636D0 (en) | 2009-08-05 | 2009-09-16 | Univ Leuven Kath | Novel viral replication inhibitors |
JP2013542243A (en) | 2010-11-15 | 2013-11-21 | カトリーケ ウニヴェルシテイト ルーヴェン | Novel antiviral compounds |
AU2012221927B2 (en) | 2011-02-25 | 2016-04-28 | Yuhan Corporation | Diaminopyrimidine derivatives and processes for the preparation thereof |
WO2013123401A1 (en) * | 2012-02-17 | 2013-08-22 | Abbvie Inc. | Diaminopyrimidines useful as inhibitors of the human respiratory syncytial virus (rsv) |
IN2014MN02314A (en) | 2012-05-29 | 2015-08-07 | Momentive Performance Mat Inc | |
CA2892045C (en) | 2012-11-21 | 2022-05-31 | Ptc Therapeutics, Inc. | Substituted reverse pyrimidine bmi-1 inhibitors |
WO2014139326A1 (en) | 2013-03-13 | 2014-09-18 | Genentech, Inc. | Pyrazolo compounds and uses thereof |
NZ748260A (en) * | 2013-08-30 | 2020-01-31 | Ptc Therapeutics Inc | Substituted pyrimidine bmi-1 inhibitors |
WO2015054317A1 (en) * | 2013-10-07 | 2015-04-16 | Kadmon Corporation, Llc | Rho kinase inhibitors |
US10584115B2 (en) | 2013-11-21 | 2020-03-10 | Ptc Therapeutics, Inc. | Substituted pyridine and pyrazine BMI-1 inhibitors |
CA2965336A1 (en) * | 2014-10-22 | 2016-04-28 | The Board Of Regents Of The University Of Texas System | Small-molecule inhibitors targeting discoidin domain receptor 1 and uses thereof |
CN105669642B (en) * | 2014-11-19 | 2020-06-09 | 江苏天士力帝益药业有限公司 | Preparation method of loflupridine hydrochloride |
JP6933322B2 (en) * | 2016-01-04 | 2021-09-08 | メルク セローノ エス.エー. | L-Valinate of hydroxypropylthiazolidinecarboxamide derivative and its salt form, polymorph |
WO2018184978A1 (en) * | 2017-04-05 | 2018-10-11 | Bayer Cropscience Aktiengesellschaft | 2-amino-5-oxyalkyl-pyrimidine derivatives and their use for controlling undesired plant growth |
CN114685369B (en) * | 2022-05-17 | 2024-02-02 | 河南省科学院高新技术研究中心 | Method for preparing 1-methyl-1, 2,3, 4-tetrahydroisoquinoline by utilizing ionic liquid |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1182584A (en) | 1966-03-31 | 1970-02-25 | Ici Ltd | Pyrimidine derivates and the use thereof as fungicides |
US3980781A (en) | 1966-03-31 | 1976-09-14 | Imperial Chemical Industries Limited | Fungicidal composition and method containing 2-amino-pyrimidines |
US4000138A (en) | 1966-03-31 | 1976-12-28 | Imperial Chemical Industries Limited | Organic compounds and compositions containing them |
US4044136A (en) | 1972-09-09 | 1977-08-23 | Pfizer Inc. | Aminoquinazoline therapeutic agents |
GB1383409A (en) | 1972-09-09 | 1974-02-12 | Pfizer Ltd | Derivatives of 2-amino- and 4-amino-quinazoline and pharmaceutical compositions containing them |
US3956495A (en) | 1973-10-30 | 1976-05-11 | Eli Lilly And Company | 2,4-Diaminoquinazolines as antithrombotic agents |
US4755218A (en) | 1985-12-31 | 1988-07-05 | Monsanto Company | Haloacyl 1-substituted-1,2,3,4-tetrahydro-isoquinolines as herbicide antidotes |
GB8621425D0 (en) * | 1986-09-05 | 1986-10-15 | Smith Kline French Lab | Compounds |
IL88507A (en) * | 1987-12-03 | 1993-02-21 | Smithkline Beckman Intercredit | 2,4-diaminoquinazolines, process for their preparation and pharmaceutical compositions comprising them |
US4966622A (en) | 1988-04-12 | 1990-10-30 | Ciba-Geigy Corporation | N-phenyl-N-pyrimidin-2-ylureas |
HU206337B (en) * | 1988-12-29 | 1992-10-28 | Mitsui Petrochemical Ind | Process for producing pyrimidine derivatives and pharmaceutical compositions |
DE3901448A1 (en) | 1989-01-19 | 1990-07-26 | Basf Ag | EMULSION COPOLYMERISATE |
EP0388838B1 (en) | 1989-03-22 | 1996-01-10 | Ciba-Geigy Ag | Parasiticide |
CA2015981A1 (en) * | 1989-05-10 | 1990-11-10 | Thomas H. Brown | Compounds |
GB8910722D0 (en) | 1989-05-10 | 1989-06-28 | Smithkline Beckman Intercredit | Compounds |
GB9012592D0 (en) | 1990-06-06 | 1990-07-25 | Smithkline Beecham Intercredit | Compounds |
DK0556310T3 (en) | 1990-11-06 | 1995-08-21 | Pfizer | Quinazoline derivatives to increase antitumor activity |
WO1992018498A1 (en) | 1991-04-17 | 1992-10-29 | Pfizer Inc. | Pyrimidine derivatives for enhancing antitumor activity |
US5276186A (en) | 1992-03-11 | 1994-01-04 | Ciba-Geigy Corporation | Process for the production of guanidine derivatives |
KR0144833B1 (en) | 1992-12-28 | 1998-07-15 | 김태훈 | Novel quinazoline derivatives and their preparation |
DE69408750T2 (en) | 1993-08-26 | 1998-07-23 | Ono Pharmaceutical Co | 4-aminopyrimidine derivatives |
RU2153494C2 (en) | 1993-10-12 | 2000-07-27 | Дзе Дюпон Мерк Фармасьютикал Компани | 1-n-alkyl-n-arylpyrimodineamines, method of patient treatment, pharmaceutical composition |
AU688087B2 (en) * | 1994-08-13 | 1998-03-05 | Yuhan Corporation | Novel pyrimidine derivatives and processes for the preparation thereof |
CN1097591C (en) | 1996-05-04 | 2003-01-01 | 株式会社柳韩洋行 | Process for preparing pyrimidine derivatives |
-
1998
- 1998-03-23 IN IN724DE1998 patent/IN188411B/en unknown
- 1998-03-24 EP EP98911242A patent/EP1015444B1/en not_active Expired - Lifetime
- 1998-03-24 RU RU99122603/04A patent/RU2203894C2/en not_active IP Right Cessation
- 1998-03-24 BR BR9808070-9A patent/BR9808070A/en not_active Application Discontinuation
- 1998-03-24 PT PT98911242T patent/PT1015444E/en unknown
- 1998-03-24 TR TR1999/02383T patent/TR199902383T2/en unknown
- 1998-03-24 AT AT98911242T patent/ATE241613T1/en not_active IP Right Cessation
- 1998-03-24 WO PCT/KR1998/000058 patent/WO1998043968A1/en active IP Right Grant
- 1998-03-24 HU HU0000851A patent/HUP0000851A3/en unknown
- 1998-03-24 CN CN98803765A patent/CN1118464C/en not_active Expired - Fee Related
- 1998-03-24 DE DE69815126T patent/DE69815126T2/en not_active Expired - Fee Related
- 1998-03-24 ES ES98911242T patent/ES2200324T3/en not_active Expired - Lifetime
- 1998-03-24 US US09/381,814 patent/US6352993B1/en not_active Expired - Fee Related
- 1998-03-24 CA CA002284795A patent/CA2284795C/en not_active Expired - Fee Related
- 1998-03-24 AU AU65239/98A patent/AU720385B2/en not_active Ceased
- 1998-03-24 DK DK98911242T patent/DK1015444T3/en active
- 1998-03-24 JP JP54148798A patent/JP3176379B2/en not_active Expired - Fee Related
- 1998-03-26 AR ARP980101380A patent/AR012181A1/en unknown
- 1998-03-26 UY UY24938A patent/UY24938A1/en not_active IP Right Cessation
- 1998-03-27 KR KR1019980010754A patent/KR100278857B1/en not_active IP Right Cessation
- 1998-03-27 TW TW087104605A patent/TW542831B/en not_active IP Right Cessation
-
2000
- 2000-09-05 HK HK00105563A patent/HK1026418A1/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU99122603A (en) | NEW PYRIMIDINE DERIVATIVES AND METHODS FOR THEIR PRODUCTION | |
RU2203894C2 (en) | Novel derivatives of pyrimidine (variants) | |
ES545885A0 (en) | A METHOD TO PREPARE 4- (4- (DIMETILAMINO) -1- (4'-FLUORO- FENIL) -1-HIDROXIBUTIL) -3- (HIDROXIMETIL) -BENZONITRILO | |
JP2005522480A5 (en) | ||
JP2004500347A5 (en) | ||
RU98120057A (en) | D-PROLINE DERIVATIVES | |
RU92016545A (en) | HETEROCYCLIC COMPOUNDS, METHOD OF THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITION | |
KR850008342A (en) | Method for preparing N-alkenyl-3-hydroxybenzo [b] thiophene-2-carboxamide derivative | |
EP0233686A3 (en) | Bis phenyl ethanol amines and bis phenyoxypropanolamines having a beta-agonist activity | |
RU92016234A (en) | DERIVATIVES 3 (2H) -PYRIDAZINONE, METHOD FOR THEIR PRODUCTION, USE, PHARMACEUTICAL COMPOSITION, METHOD | |
RU2001109228A (en) | Unsaturated derivatives of hydroxy acid as inhibitors of NAD + -ADP-ribosyltransferase | |
RU2002123334A (en) | Derivatives of dibenzene (B, F) azepine and their preparation | |
JP2001518468A5 (en) | ||
RU2214404C2 (en) | Thiazole derivatives, method for preparing and pharmaceutical composition based on thereof | |
RU98103460A (en) | DERIVATIVES OF BENZENESULPHONAMIDE, THEIR PRODUCTION AND THERAPEUTIC USE | |
CA2100637A1 (en) | Process for the production of 2-substituted-5-chlorimidazole-4-carbaldehydes | |
IE781167L (en) | Ó-halomethyl amino acids. | |
IE42403L (en) | Naphthyl derivatives | |
RU2001116601A (en) | NEW PYRIMIDINE DERIVATIVES AND METHODS FOR PRODUCING THEM | |
RU2000108477A (en) | STEREOISOMERIC INDOLIC COMPOUNDS, METHOD FOR PRODUCING THEM AND USE THEREOF | |
EA200200352A1 (en) | PHENYL-AND PYRIDYL-TETRAHYDROPYRIDINES, possessing inhibitory activity in relation to tumor necrosis factor (TNF) | |
KR890005136A (en) | Azetidinone N-phosphonomethyl ester | |
RU95117103A (en) | Derivatives of quinoline carboxylic acid and methods of their synthesis | |
ES521080A0 (en) | A PROCEDURE FOR PREPARING A PURE ENANTIOMER FROM A SUBSTITUTED ALKAN PHENYLAZINE. | |
EP0110169A3 (en) | 4-(benzisothiazol-3-yl)phenoxyacetic-acid l',l'-dioxides, a process for preparing the same, intermediates thereof and their use as medicaments |